Emanuela Palmerini
Doctor
Musculoskeletal Oncology
Orthopaedic Rizzoli Institute
Italy
Biography
2004-2005: AIRC Research Grant, Ospedale Bellaria Bologna (FIRC: Italian Foundation for Cancer Research): Mechanisms of endocrine therapy resistance: estrogen receptor and epidermal growth factor receptor in breast cancer; 2013: 3-year Young Investigators Translational Research Grant “Alessandro Liberati”: Assessment of MGMT promoter methylation and clinical benefit from temozolomide-based therapy in Ewing sarcoma patients.
Research Interest
Musculoskeletal Oncology, Bone and Soft Tissue tumors Clinical Research Protocols.
Publications
-
Ferrari S, Ruggieri P, Cefalo G, Tamburini A, Capanna R, Fagioli F, Comandone A, Bertulli R, Bisogno G, Palmerini E, Alberghini M. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. Journal of clinical oncology. 2012 May 7;30(17):2112-8.
-
Bacci G, Rocca M, Salone M, Balladelli A, Ferrari S, Palmerini E, Forni C, Briccoli A. High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. Journal of surgical oncology. 2008 Nov 1;98(6):415-20.
-
Ferrari S, Palmerini E. Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma. Current opinion in oncology. 2007 Jul 1;19(4):341-6.
